INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 135 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $299,726 | +8.0% | 5,754 | +31.3% | 0.00% | – |
| Q2 2023 | $277,405 | -13.0% | 4,381 | -52.9% | 0.00% | -100.0% |
| Q4 2019 | $319,000 | +20.4% | 9,300 | -54.5% | 0.00% | 0.0% |
| Q2 2019 | $265,000 | +6.4% | 20,425 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $249,000 | +9.2% | 20,425 | +2.1% | 0.00% | 0.0% |
| Q4 2018 | $228,000 | +1972.7% | 20,000 | +2122.2% | 0.00% | – |
| Q2 2017 | $11,000 | -26.7% | 900 | 0.0% | 0.00% | – |
| Q1 2017 | $15,000 | +1400.0% | 900 | +1536.4% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 55 | -57.7% | 0.00% | – |
| Q3 2016 | $2,000 | – | 130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |